Octapharma AG - Strategy, SWOT and Corporate Finance Report
Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Octapharma (or 'the group') is engaged in research and development of human proteins for various therapeutic areas. The group operates in Europe, North and South Americas, Asia Pacific and the Middle East. It is headquartered in Lachen, Switzerland, and employed 5,683 people as on December 31, 2014.
Detailed information on Octapharma AG required for business and competitor intelligence needs
A study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis
An in-depth view of the business model of Octapharma AG including a breakdown and examination of key business segments
Intelligence on Octapharma AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Octapharma AG, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Octapharma AG and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Octapharma AG as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Octapharma AG's business structure, strategy and prospects.